-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Titan Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$19K, a 1050% decline year-over-year.
- Titan Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.67M, a 2154% increase year-over-year.
- Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $1.71M, a 5790% increase from 2022.
- Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $29K, a 95% decline from 2021.
- Titan Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was $578K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)